Stay updated on Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.

Latest updates to the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe page updated to reflect that recruitment is now open in Berlin, Germany (postal code 12203) as of 2025-10-15, replacing the previous status and location data (Berlin, 12200) with an earlier date (2025-10-01 to 2025-10-02).SummaryDifference1%

- Check16 days agoNo Change Detected
- Check23 days agoChange Detected- Core content updated: recruitment status changed from 'Active, not recruiting' to 'Recruiting', location count increased from 238 to 239, and revision/version updated from v3.1.0 to v3.2.0. - Time-sensitive details (dates, status, and locations) were refreshed, reflecting new operating and recruitment information. - Added general government-status notice; not central to the study details.SummaryDifference2%

- Check30 days agoChange DetectedUpdates reflect a shift from older terminology (plasma cell myeloma) to newer phrasing (multiple myeloma), updated versioning (v3.1.0 vs v3.0.2), a recruiting status change, and the inclusion of a contact phone number with current dates.SummaryDifference0.6%

- Check37 days agoChange DetectedUpdated institution name and status: added 2025-09-16 entry for University of Miami Hospital and Clinics recruiting, replacing a prior entry that indicated the same entity as University of Miami Hospital And Clinics and that it was active, not recruiting. The page now reflects ongoing recruiting as of 2025-09-15, with removals of older dates (2025-09-04 and 2025-09-02) and the initial naming variants.SummaryDifference0.5%

- Check44 days agoChange DetectedUpdated to v3.0.2; removed the older revision tag (v3.0.1) and the 'Back to Top' link, and deleted the MedlinePlus Genetics topic 'Multiple myeloma' from related topics. Core page content remains unchanged.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page has been updated to reflect that the study is now recruiting and has increased the number of locations from 237 to 238, with the latest revision noted as v3.0.1.SummaryDifference0.8%

Stay in the know with updates to Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.